Skip to main content
. 2016 Feb 9;7(4):361–372. doi: 10.1177/1947603515627342

Figure 2.

Figure 2.

The surface marker expression was determined by flow cytometry for donor #1, who was 21 years old. (A) CD44-positive, (B) CD105-positive, (C) both negative, and (D) both positive. FACS analysis showed that more than 93.5% of the bone marrow–derived mesenchymal stem cells (BMSCs) expressed both CD44 and CD105.